Tablet formulation for CGRP active compounds | Patent Publication Number 20210085612

US 20210085612 A1
Patent NumberUS 11925709 B2
Application Number17110398
Filled DateDec 3, 2020
Priority DateFeb 5, 2014
Publication DateMar 25, 2021
Original AssigneeMerck & Co. Inc.
Current AssigneeMerck Sharp & Dohme
Inventor/ApplicantsParesh B. Patel
Wei Xu
Hanmi Xi
Leonardo Resende Allain
Melanie Marota
Francis J. Flanagan, Jr.
Mary Ann Johnson
Francis J. Flanagan, JR.
Rebecca Nofsinger
Lisa Lupton
Chad D. Brown
W. Mark Eickhoff
Craig B. Ikeda
Patent Prosecution report image

Empower your practice with Patexia Publication Prosecution IP Module.

Get access to our exclusive rankings and unlock powerful data.

Looking for a Publication Attorney?

Get in touch with our team or create your account to start exploring a network of over 120K attorneys.